Colombian consensus recommendations for diagnosis, management and treatment of the infection by SARS-COV-2/ COVID-19 in health care facilities - Recommendations from expert´s group based and informed on evidence

La Asociación Colombiana de Infectología (ACIN) y el Instituto de Evaluación de Nuevas Tecnologías de la Salud (IETS) conformó un grupo de trabajo para desarrollar recomendaciones informadas y basadas en evidencia, por consenso de expertos para la atención, diagnóstico y manejo de casos de Covid 19. Estas guías son dirigidas al personal de salud y buscar dar recomendaciones en los ámbitos de la atención en salud de los casos de Covid-19, en el contexto nacional de Colombia

Sistematizar los procesos administrativos y logísticos de los programas

Este documento describe la implementación de la metodología de trabajo Scrum para el planteamiento del proyecto de la Universidad Cooperativa de Colombia que consiste en Sistematizar los procesos administrativos y logísticos de los programas de la UCC sede Bucaramanga. Incluye junto con la descripción de este ciclo de vida iterativo e incremental para el proyecto, los documentos con los que se gestionan las asignaciones de aulas y áreas comunesDESCRIPCIÓN DE LA METODOLOGÍA DE TRABAJO -- INTRODUCCIÓN -- PROPÓSITO DE ESTE DOCUMENTO -- CASO DE NEGOCIO -- DEFINICIÓN DEL PROBLEMA -- VISION DEL PROYECTO -- VALORES DE TRABAJO -- DESIGNACIÓN DEL PRO. OWNER -- ACTA DE DESIGNACIÓN DE P. OWNER -- DESIGNACIÓN DE LOS SCRUM MASTER -- ACTA DE DESIGNACIÓN DE LOS SCRUM MASTER -- MATRIZ DE INTERESADOS -- DEFINICION DEL EQUIPO SCRUM -- DEFINICION DEL EQUIPO SCRUM – MODULO SALONES -- PROTOTIPO DE USUARIOS -- Administrator -- Docente -- Estudiante -- Agente Externo -- CREACIÓN DEL PRODUCT BACKLOG -- PRIORIZACIÓN DE TAREAS -- CRITERIOS DE ACEPTACION Y creacion de tareas -- CRONOGRAMA DE LANZAMIENTO -- REQUERIMIENTOS FUNCIONALES -- REQUERIMIENTO NO FUNCIONALES -- Eficiencia -- Usabilidad -- REUNION DAILY MEETING -- DAILY MEETING EQUIPO MODULO SALONES -- DAILY MEETING EQUIPO MODULO EVENTOS -- EVIDENCIA RETROSPECTIVA DEL SPRINT -- Entregables -- ENTREGABLES MODULO SALONES -- CONCLUSIONES Y RECOMENDACIONES -- [email protected]@[email protected]@[email protected]@[email protected]@[email protected]@[email protected]@[email protected]@[email protected]

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0 ± 10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n = 6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n = 15,449, 56.1%) and North America (n = 8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH